Published in Infect Immun on May 01, 1999
Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine. Parasite Immunol (2010) 1.49
Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosis. Infect Immun (2001) 0.94
Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response. Infect Immun (2001) 0.90
Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis. Infect Immun (1999) 0.90
Immunoregulation by Taenia crassiceps and its antigens. Biomed Res Int (2012) 0.84
Towards identification of the mechanisms of action of parasite-derived peptide GK1 on the immunogenicity of an influenza vaccine. Clin Vaccine Immunol (2009) 0.82
Apoptosis induced by gamma irradiation of Taenia solium metacestodes. Parasitol Res (2003) 0.81
Heterologous prime-boost oral immunization with GK-1 peptide from Taenia crassiceps cysticerci induces protective immunity. Clin Vaccine Immunol (2011) 0.80
Immunoinformatics prediction of linear epitopes from Taenia solium TSOL18. Bioinformation (2011) 0.78
Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine. PLoS One (2010) 0.78
Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells. Planta (2015) 0.77
The synthetic parasite-derived peptide GK1 increases survival in a preclinical mouse melanoma model. Cancer Biother Radiopharm (2013) 0.77
Taenia solium: Development of an Experimental Model of Porcine Neurocysticercosis. PLoS Negl Trop Dis (2015) 0.75
Analysis of the expression of cytoskeletal proteins of Taenia crassiceps ORF strain cysticerci (Cestoda). Parasitol Res (2014) 0.75
Transgenic papaya: a useful platform for oral vaccines. Planta (2017) 0.75
MHC ligands and peptide motifs: first listing. Immunogenetics (1995) 7.78
Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation. J Immunol (1995) 1.42
Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin Immunol (1997) 1.41
Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol (1992) 1.33
Hydatidosis/cysticercosis: immune mechanisms and immunization against infection. Adv Parasitol (1982) 1.27
Shift from an early protective Th1-type immune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps). J Parasitol (1998) 1.25
Deciphering western blots of tapeworm antigens (Taenia solium, Echinococcus granulosus, and Taenia crassiceps) reacting with sera from neurocysticercosis and hydatid disease patients. Am J Trop Med Hyg (1989) 1.19
Cysticercosis vaccine: cross protecting immunity with T. solium antigens against experimental murine T. crassiceps cysticercosis. Parasite Immunol (1990) 1.10
Laboratory diagnosis of cysticercosis. Clin Lab Med (1991) 1.04
Increased resistance to Taenia crassiceps murine cysticercosis in Qa-2 transgenic mice. Infect Immun (1998) 1.01
Cysticercosis: identification and cloning of protective recombinant antigens. J Parasitol (1996) 0.99
Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs. Vet Parasitol (1997) 0.99
Immunization against Taenia crassiceps cysticercosis: identification of the most promising antigens in the induction of protective immunity. J Parasitol (1994) 0.97
[Seroepidemiology of cysticercosis in Mexico]. Salud Publica Mex (1992) 0.93
Immunization of pigs against Taenia solium cysticercosis: factors related to effective protection. Vet Parasitol (1995) 0.93
Growth rate of two Taenia crassiceps strains. Exp Parasitol (1969) 0.92
Effective immune protection of pigs against cysticercosis. Vet Immunol Immunopathol (1995) 0.91
A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelii vaccine in the mouse. Parasite Immunol (1982) 0.90
Antigens of parasitic helminths in diagnosis, protection and pathology. Parasitology (1989) 0.86
Immunodominant synthetic peptides of Taenia crassiceps in murine and human cysticercosis. Immunol Lett (1996) 0.83
Analysis of the immune response elicited by a multiple antigen peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni. Parasite Immunol (1997) 0.82
Cysticercosis. Curr Clin Top Infect Dis (1996) 0.82
[Development of an immunoenzyme test for the diagnosis of human cysticercosis using a heterologous antigen]. Parassitologia (1995) 0.78
A Pluto-like radius and a high albedo for the dwarf planet Eris from an occultation. Nature (2011) 2.91
Mitochondrial DNA analysis of northwest African populations reveals genetic exchanges with European, near-eastern, and sub-Saharan populations. Ann Hum Genet (1998) 2.43
Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer (2001) 2.22
Atrial septal aneurysm. Is it a benign finding? Int J Cardiol (1999) 2.03
TGF-beta receptors and actions. Biochim Biophys Acta (1994) 1.78
Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis. J Neurol Neurosurg Psychiatry (2007) 1.77
Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis. Circulation (1996) 1.73
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health Technol Assess (2012) 1.70
Horseshoe lung: clinical, pathologic, and radiologic features and a new plain film finding. AJR Am J Roentgenol (1986) 1.66
Genetic relationship between the Canary Islanders and their African and Spanish ancestors inferred from mitochondrial DNA sequences. Ann Hum Genet (1996) 1.57
PMR1, a Ca2+-ATPase in yeast Golgi, has properties distinct from sarco/endoplasmic reticulum and plasma membrane calcium pumps. J Biol Chem (1997) 1.57
Prevention of intraventricular hemorrhage during CSF shunt revisions by means of a flexible coagulating electrode. A preliminary report. Childs Nerv Syst (1998) 1.57
Sex in the New World: an empowerment model for HIV prevention in Latina immigrant women. Health Educ Behav (1999) 1.56
Did algal toxins cause monk seal mortality? Nature (1998) 1.53
Characterization of BCE-1, a transcriptional enhancer regulated by prolactin and extracellular matrix and modulated by the state of histone acetylation. Mol Cell Biol (1998) 1.52
Phylogenetic relationships of the Canary Islands endemic lizard genus Gallotia (Sauria: Lacertidae), inferred from mitochondrial DNA sequences. Mol Phylogenet Evol (1996) 1.51
Dietary factors in epidemic neuropathy on the Isle of Youth, Cuba. Bull Pan Am Health Organ (1995) 1.50
Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions. Microbes Infect (2000) 1.45
[Hypertension programs and the risk of ischemic cardiopathy]. Aten Primaria (1994) 1.41
Common ground: an analytic break and its consequences. Int J Psychoanal (1990) 1.40
[Current use of penicillin in community-acquired pneumococcal pneumonias]. Enferm Infecc Microbiol Clin (1994) 1.39
[Heparinoids versus nitroglycerin in the treatment of superficial phlebitis]. Rev Clin Esp (1993) 1.38
[Thallium-201 scintigraphy and dobutamine echocardiography in the assessment of myocardial viability]. Rev Clin Esp (2001) 1.38
Brachiocephalic jump graft fistula: an alternative for dialysis use of elbow crease veins. Am J Kidney Dis (1999) 1.37
Role of reversible phosphorylation of acetyl-CoA carboxylase in long-chain fatty acid synthesis. FASEB J (1989) 1.36
Phylogeographic patterns of mtDNA reflecting the colonization of the Canary Islands. Ann Hum Genet (1999) 1.33
Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol (1992) 1.33
Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter. Mol Endocrinol (1994) 1.31
High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology (2003) 1.30
Synthesis and antiparasitic activity of 2-(trifluoromethyl)-benzimidazole derivatives. Bioorg Med Chem Lett (2001) 1.27
Immunodiagnosis of human cysticercosis in cerebrospinal fluid. Antigens from murine Taenia crassiceps cysticerci effectively substitute those from porcine Taenia solium. Arch Pathol Lab Med (1990) 1.26
Shift from an early protective Th1-type immune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps). J Parasitol (1998) 1.25
Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr) (2007) 1.20
Deciphering western blots of tapeworm antigens (Taenia solium, Echinococcus granulosus, and Taenia crassiceps) reacting with sera from neurocysticercosis and hydatid disease patients. Am J Trop Med Hyg (1989) 1.19
Influence of chromatin structure on the binding of transcription factors to DNA. Cold Spring Harb Symp Quant Biol (1993) 1.18
Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition. Mol Cell Biol (2000) 1.17
Human cysticercosis: antigens, antibodies and non-responders. Clin Exp Immunol (1980) 1.17
Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine (2001) 1.16
A new syndrome of triphalangeal thumbs and brachy-ectrodactyly. Clin Genet (1980) 1.16
The settlement of Patagonia: a matrix correlation study. Hum Biol (2001) 1.15
Cry1Ac protoxin from Bacillus thuringiensis sp. kurstaki HD73 binds to surface proteins in the mouse small intestine. Biochem Biophys Res Commun (2000) 1.14
Reliable serology of Taenia solium cysticercosis with antigens from cyst vesicular fluid: ELISA and hemagglutination tests. Am J Trop Med Hyg (1986) 1.13
Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A. J Biol Chem (2001) 1.13
Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding. J Biol Chem (1997) 1.12
Transcriptional state of the mouse mammary tumor virus promoter can affect topological domain size in vivo. J Biol Chem (1999) 1.11
Qa-2-dependent selection of CD8alpha/alpha T cell receptor alpha/beta(+) cells in murine intestinal intraepithelial lymphocytes. J Exp Med (2000) 1.10
Cysticercosis vaccine: cross protecting immunity with T. solium antigens against experimental murine T. crassiceps cysticercosis. Parasite Immunol (1990) 1.10
Typical isolated ectrodactyly of hands and feet: early antenatal diagnosis. J Matern Fetal Neonatal Med (2005) 1.09
Limitations of current diagnostic procedures for the diagnosis of Taenia solium cysticercosis in rural pigs. Vet Parasitol (1998) 1.08
Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection. Infect Immun (1995) 1.08
Molecular cloning of cDNA for acetyl-coenzyme A carboxylase. J Biol Chem (1986) 1.08
Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent. Biochem J (2001) 1.06
The frequency and economic burden of genetic disease in a pediatric hospital in Mexico City. Am J Med Genet (1985) 1.05
Dysplasia epiphysealis hemimelica. J Pediatr Orthop (1984) 1.04
Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab (1997) 1.04
Proton pumping and the internal pH of yeast cells, measured with pyranine introduced by electroporation. J Bacteriol (1995) 1.04
An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg (2005) 1.04
Murine Taenia crassiceps cysticercosis: H-2 complex and sex influence on susceptibility. Parasitol Res (1991) 1.03
Nosocomial infection by VIM-2 metallo-beta-lactamase-producing Pseudomonas putida. J Med Microbiol (2010) 1.03
Acetyl-CoA carboxylase mRNA species with or without inhibitory coding sequence for Ser-1200 phosphorylation. J Biol Chem (1990) 1.03
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients. Leukemia (2013) 1.03
Functional capacity of children with leukemia. Int J Sports Med (2007) 1.03
Characterization of Lactobacillus sake isolates from dry-cured sausages by restriction fragment length polymorphism analysis of the 16S rRNA gene. J Appl Microbiol (1998) 1.03
Cancer risk in an arsenic-contaminated area of Chile. Toxicol Ind Health (1997) 1.03
TGF-beta receptors. Mol Reprod Dev (1992) 1.03
Phenotypic screening of mutations in Pmr1, the yeast secretory pathway Ca2+/Mn2+-ATPase, reveals residues critical for ion selectivity and transport. J Biol Chem (2000) 1.03
Sex hormone changes induced by the parasite lead to feminization of the male host in murine Taenia crassiceps cysticercosis. J Steroid Biochem Mol Biol (1995) 1.03
Neurocysticercosis: detection of Taenia solium DNA in human cerebrospinal fluid using a semi-nested PCR based on HDP2. Ann Trop Med Parasitol (2008) 1.02
Diagnosis of porcine cysticercosis: a comparative study of serological tests for detection of circulating antibody and viable parasites. Vet Parasitol (1998) 1.02
Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Trans R Soc Trop Med Hyg (2004) 1.01
Increased resistance to Taenia crassiceps murine cysticercosis in Qa-2 transgenic mice. Infect Immun (1998) 1.01
Acute effects of ozone on the pulmonary function of exercising schoolchildren from Mexico City. Am J Respir Crit Care Med (1995) 1.00
High antibody levels to the mycobacterial fibronectin-binding antigen of 30-31 kD in tuberculosis and lepromatous leprosy. Clin Exp Immunol (1992) 1.00
Th1-type cytokines improve resistance to murine cysticercosis caused by Taenia crassiceps. Parasitol Res (1999) 0.99
Cysticercosis: identification and cloning of protective recombinant antigens. J Parasitol (1996) 0.99
Castration and pregnancy of rural pigs significantly increase the prevalence of naturally acquired Taenia solium cysticercosis. Vet Parasitol (2002) 0.99